By Doug Madison BTIG Research set a $13.00 price objective on Histogenics Corp (NASDAQ:HSGX) in a research report released on Thursday morning. The firm currently has a a buy rating on the stock. Shares of Histogenics Corp (NASDAQ:HSGX) traded down